Session 1196: Predictive Markers

Cochair(s): G de The, A Gazdar
Date: Mon 11 February 2002, Time: 14:00 - 16:00
Location: Amphithéâtre Monod

Oral Presentations

Time Number Title / Authors / Affiliations
14:00 299 The predictive power of premalignant lesions of the stomach.
A Grace, C Gulmann, D Butler, M Leader, E Kay
Department of Pathology, Royal College of Surgeons in Ireland, Dublin Ireland
14:15 300 Influence of PUFA on a prospective cancer biomarker in feline adipose
KE Saker, BE Cowing, JH Herbein
1VA-MD Regional College of Veterinary Medicine, and Department of Dairy Science, , 2VA-MD Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA
14:30 301 Oligoclonal expansion of B cells in the livers of hepatitis C virus infection may be associated with the development of B-cell non-Hodgkin lymphomas.
J Murakami, Y Shimizu, Y Kashii, K Ebata, T Kato, A Watanabe
Toyama Medical and Pharmaceutical University, Toyama, Toyama Japan
14:45 302 Utilising the comet assay for the detection of mouse models in a large scale genetic screen to determine genetic components of radiation sensitivity
CA Schindewolf, A Hartmann, HV Liebscher, W Frieauff, H Fuchs, E Binder, F Ohl, D Soewarto, H Gomolka, T Jung, H de Angelis
1Institute for Experimental Genetics, 3Institute for Biomathematics and Biometry; GSF Research Centre for Health and Environment, Neuherberg, Germany, 2Novartis Pharma AG, Preclinical Safety, Basel, Switzerland, 4Max-Planck-Institute of Psychiatry, Munich, Germany, 5Institute for Radiation Hygiene, Federal Office of Radiation Protection, Neuherberg, Germany
15:00 303 DNA repair gene polymorphisms and adult acute myeloblastic leukaemia risk
CH Seedhouse, EP Das-Gupta, M Lewis, NH Russell
Deparmtent of Academic Haematology, Clinical Sciences Building, Nottingham, NG5 1PB
15:15 304 Genomic analysis of scirrhous gastric cancer in a young adult
H Mita, F Itoh, M Toyota, K Imai
First Department of Internal Medicine, School of Medicine, Sapporo Medical University, Sapporo, Hokkaido Japan
15:30 305 Molecular and histopathologic predictors of distant failures in corpus cancer
A Mariani, TJ Sebo, J Katzman, D Riehle, GL Keeney, KC Podratz
Mayo Clinic, Rochester, MN United States
15:45 306 Relationship of microvessel density and VEGF with dynamic MRI parameters in breast cancer
O Nalcioglu, M-Y Su, J Fruehauf, Y-C Cheung, E Mechetner, A Kyshtoobayeva, S-C Chen, S Hsueh, Y-L Wan
1John Tu & Thomas Yuen Center for Functional Onco-Imaging, University of California, Irvine, USA, 2Oncotech Inc. Irvine, USA, 3Linko Chang Gung Memorial Hospital, Taiwan

Poster Presentations

Number Title / Authors / Affiliations
307 Clinical implications of p53 tumor suppressor gene alterations in esophageal adenocarcinoma: results of a 10-year prospective study
AG Casson, S Evans, A Gillis, GA Porter, PJ Veugelers, SJ Darnton, DL Guernsey, P Hainaut
1Dalhousie University, Halifax, Nova Scotia Canada, 2International Agency for Research on Cancer, Lyon, France
308 Bcl-2, bax, and p53 immunohistochemical alternations as predictive markers for radiotherapy in patients with localized prostate cancer.
S Kariya, Y Ogawa, A Nishioka, M Furihata, K Kasahara, K Inoue, T Shuin, S Yoshida
1Department of Radiology, 22nd Department of Pathology, 3Department of Urology; Kochi Medical School, Nankoku, Kochi, Japan
309 *Microvascular Changes During Inhibition of Colorectal Liver Metastases by SMANCS/Lipiodol.
D Kuruppu, H Maeda, C Christophi, PE O'Brien
1Dept of Surgery, Monash Medical School, Alfred Hospital, Japan, , 2Dept of Microbiology, Kumamoto University School of Medicine, Japan
310 Immunohistochemical expression of caveolin-1 as a marker for the biological potential of renal cell carcinoma
H Sakai, K Takehara, S Koga, H Kanetake
Department of Urology, Nagasaki University School of Medicine, Nagasaki, Japan
311 Cancer markers shown to be a cause as well as a consequence of cancer activity
MS Beljanski
Ingenieur d'etude au CNRS, Scientific Attache, Molecular International Research, Inc, New York, NY [ok]
312 Factors of cancer tolerance: increased prevalence of GSTM1 proficiency in elderly tumour-free smokers and non-smokers
EN Imyanitov, AV Togo, EV Belogubova, VG Lemehov, KP Hanson
N.N. Petrov Institute of Oncology, St.-Petersburg, Russia
313 Susceptibility genes for bladder cancer
S Horn, E Schnakenberg, R Werdin, K Dreikorn, W Schloot
1AdnaGen AG, Hannover-Langenhagen, Lower Saxony Germany, 2Urological Division, St. Jürgen Hospital of Bremen, Germany, 3Center for Human Genetic and Genetic Counselling, University of Bremen, Germany
314 Potential protein markers in diagnosis and treatment of B-CLL
M Rogalinska, J Blonski, M Hanausek, T Robak, ZM Kilianska
1Department of Cytobiochemistry, University of Lodz, Banacha 12/16, Lodz, Poland, 2Department of Hematology, Medical University of Lodz, Lodz, Poland, 3AMC Cancer Research Center, Denver, USA
315 Identification and molecular characterization of NUCB2 as potential gastric cancer antigen
Z Slucka, A Line, A Stengrevics, G Li, E Jankevics, RC Rees
1Biomedical Research and Study Centre, University of Latvia, Riga, Latvia, 2Latvian Oncology Center, Riga, Latvia, 3Department of Life Sciences, Nottingham Trent University, Nottingham, UK
316 The detection of early p53 mutations in non-dysplastic Barrett's tissues.
GJS Jenkins, SH Doak, AP Griffiths, JM Parry, JN Baxter
1Molecular Pathology Group, Swansea Clinical School, University of Wales Swansea, , 2School of Biological Sciences, University of Wales Swansea, , 3Department of Pathology, Morriston Hospital
317 Characterization of an estrogen-regulated growth factor in endometrial cancer
MB Jones, A Houwink, WL Lingle, EC Kohn, A Berchuck, KC Podratz, NJ Maihle
1Mayo Clinic, Rochester, MN United States, 2National Cancer Institute, Bethesda, MD United States, 3Duke University Medical Center, Durham, NC United States
318 *Clinical impact of circulating tumor cells (CTC) morphological and molecular (ß catenin mutations) characterization in patients with hepatocellular carcinoma
G Vona, L Estepa, D Damotte, F Capron, C Béroud, H Fontaine, A Mineur, B Nalpas, H Zylberberg, D Franco, B Lacour, S Pol, C Bréchot, P Paterlini-Bréchot
1INSERM U370, Services, Paris, 2Biochimie, Hôpital Necker, Paris, 3Hepatologie, Hôpital Necker, Paris, 4Anatomie-Pathologique, Hôpital Necker, Paris, 5Chirurgie Digestive, Hôpital A. Beclère, Clamart, 6Anatomie-Pathologique, Hôpital A. Beclère, Clamart
319 p53 gene alterations in lymph node-positive breast cancer patients on adjuvant chemotherapy
M Brankovic-Magic, R Jankovic, Z Magic, B Cikota, S Radulovic
1Institute for Oncology and Radiology of Serbia, Belgrade, Yugoslavia, 2Institute for Medical Research, Belgrade, Yugoslavia
320 Sarcolectin plays a role in normal and malignant cell growth
F Chany, C Chany
1Universite Rene Descartes. Laboratoire des Interferons et de la Sarcolectine, Paris Cedex 06, France, 2ADBEA, Service de Chirurgie Ortbopedique, H6pital Saint-Vincent-de-Paul, 82 Avenue Denfert Rocbereau, 3Beijing Chemical Reagent Institute, Jiulongsham, East Suburb, Beijing China
321 *Expression of human Telomerase Reverse Transcriptase (hTERT) mRNA in tumor cells from urine, as tumor marker for monitoring both relapse and urothelial microdissemination in bladder carcinoma
N álvarez, F árias, E Fernández, A Escudero, G Gómez, A Gómez, MV Toledo, A Moyano, E Caso
1Laboratorio de Oncología Molecular Aplicada. Servicio de Oncología Médica, Hospital Ramón y Cajal. Madrid. Spain, , 2Servicio de Urología, Hospital Ramón y Cajal. Madrid. Spain
322 Androgen-sensitive prostate cancer is characterized by a lower malignant potential
L Bonaccorsi
Department of Clinical Physiopathology University of Florence Viale Pieraccini 6 I-50134 Florence, Italy
323 The estimation of adhesion molecules sICAM-1, sICAM-2, sVCAM-1, sCD44 ST, sCD44 V5 and dendritic cells function in children with malignancies
J Weclawek-Tompol, A Chybicka, B Rybka, R Ryczan, D Noworolska, J Boguslawska-Jaworska
Department of Children Hematology and Oncology, Medical University of Wroclaw, Poland
324 Mixed myelodysplastic and myeloproliferative syndromes (MDS-MPS), a new stem cell disorder.
R Neuwirtová, K Michalová, B Novotná
11st Med.Clin. Dept.Clin.Hematol. Charles Univ.Hospital, Prague, Czech Republic, 23rd Med.Clin. Dept.Cytogenetics Charles Univ.Hospital, Prague, Czech Republic, 3Inst.Exper.Medicine Academy Sci, Prague, Czech Republic
325 DNA content as a possible marker of preneoplasia in renal cysts with comparison of solid and cystic renal cancer.
J Kovacs, E Szabo, A Varga, T Nemeth, S Gomba, J Kappelmayer
Department of Pathology, Department of Urology, and Department of Clinical Biochemistry and Molecular Pathology, University of Debrecen Medical and Health Science Center, Debrecen, Hungary
326 Prognosis value of cytokine levels in response to chemotherapy in non small cell lung cancer
BA Alvarez, A Valls, L Muñoz, O Rodríguez, C Jurado, R Rodríguez, M Riera, G Reimers, S Fernández, B López
1Department of Internal Medicine, Service of Oncolgy Medicine and Department of Medicine, Service Internal Medicine, , 2Hospital Universitario de Canarias. Tenerife. Spain